Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congress Likely To Vote On Cures Bill Package After Thanksgiving

Executive Summary

Back-to-back votes from the House and Senate on matching medical innovation bills, including provisions streamlining FDA device oversight, is expected the week of Nov. 28, with "pay-fors" expected to come from the Strategic Petroleum Reserve fund and the Prevention and Public Health Fund.

You may also be interested in...



Innovation Bill Scorecard: Device, Diagnostic Provisions In Senate And House

On April 6, the Senate HELP Committee finished the last of three markup sessions on medical innovation bills designed to be the Senate's version of the 21st Century Cures Act, which passed the House last July. Check out this Gray Sheet chart that lists device-relevant bills that have passed through the HELP Committee aligned with similar House Cures' provisions.

US Senate Committee Advances Device Review Reform Bills

A US Senate panel approved seven medical product reform bills Feb. 9 by unanimous consent, including three that would affect device regulation1.

White House To Deliver 25 Million Face Masks To Low-Income Americans

The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104121

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel